Error: Could not add to watchlist. X

Pharmacyclics Inc

+ Watchlist
PY2:GR
Dusseldorf
236.01
EUR
0.13
0.06%
As of 08:10:37 ET on 05/26/2015.
Open
235.80
Day Range
235.75 - 236.55
Volume
20
Previous Close
236.14
52Wk Range
63.37 - 246.65
1 Yr Return
255.75%
Current P/E Ratio (TTM)
-
Earnings per Share (USD) (TTM)
-
Market Cap (b EUR)
18.191
Shares Outstanding (m)
77.079
Price/Sales (TTM)
-
Dividend Indicated Gross Yield
-
Sector
Health Care
Industry
Biotech & Pharma
Sub-Industry
Biotech
Profile
Pharmacyclics, Inc. is a clinical-stage biopharmaceutical company focused on discovering and developing innovative small-molecule drugs for the treatment of cancer and immune mediated diseases. The Company's pharmaceutical drug development candidates are synthetic small-molecules designed to target key biochemical pathways involved in human diseases with critical unmet needs.
ADDRESS
995 East Arques Avenue
Sunnyvale, CA 94085-4521
United States
PHONE
1-408-774-0330
  • Robert W Duggan "Bob"
    Chairman/CEO
  • Manmeet Soni
    CFO/Treasurer
  • Mahkam Zanganeh "Maky"
    Chief Operating Officer
  • Shawn Cline Tomasello
    Chief Commercial Officer
  • Jesse McGreivy
    Chief Medical Officer
Show More